A*STAR Outstanding Publications Award 2009, 2010, 2012 and 2013
A*STAR Patent Power Award 2009 and 2010
Singapore HEALTH Award (Platinum) 2012, (Gold) 2008 and 2010
Nanotechnology Experts to Gather in Singapore for 3rd Nano Today Conference
December 3, 2013 – Over 400 scientists worldwide will converge in Singapore for the 3rd Nano Today Conference which will be held at the Biopolis on December 9 to 11, 2013. Organized by Nano Today, a leading journal for nanoscience and nanotechnology, the Institute of Bioengineering and Nanotechnology (IBN) and Elsevier, the three-day conference will showcase the latest research advances in nanostructured materials and systems for diverse applications in areas such as biomedical, electronic, chemical and energy.
Chaired by Nano Today Editor-in-Chief and IBN Executive Director, Professor Jackie Y. Ying, this conference will feature 3 plenary lectures by Professor Younan Xia (Georgia Institute of Technology, USA), Professor Joseph M. DeSimone (University of North Carolina, USA) and Professor Mostafa A.
El-Sayed (Georgia Institute of Technology, USA), invited talks by 25 distinguished scientists from internationally renowned institutions, as well as 17 contributed oral and over 220 poster presentations.
“Nanotechnology offers a new approach to tackling many problems, and the numerous research breakthroughs in recent years have demonstrated the potential of this rapidly evolving field. The Nano Today conference series aim to feature the latest advances and applications of nanotechnology. IBN is delighted to host the third conference in Singapore with Nano Today and Elsevier. We are honored to have a large number of leading experts as invited speakers for our conference, and the participation of researchers and students from 45 countries. We look forward to a stimulating and exciting meeting,” said Professor Jackie Y. Ying.
New Hydrogel from IBN and IBM Improves Delivery of Anti-Cancer Drug
Research breakthrough promises more efficient breast cancer treatment
The IBN research team comprising Dr Yi Yan Yang, Dr Victor Ng, Dr Shujun Gao and Dr Ashlynn Lee (anti-clockwise from bottom right)
October 31, 2013 – The Institute of Bioengineering and Nanotechnology (IBN) and IBM Research (IBM) have developed a new non-toxic hydrogel that is capable of shrinking breast cancer tumors more rapidly than existing therapies. As described in their publication in Advanced Functional Materials, the Vitamin E-incorporated hydrogel can be easily injected under the skin without causing any inflammatory response, and releases anti-cancer drugs in a sustained manner over several weeks. This reduces the need for frequent drug administration, paving the way for the tumors to be eradicated in fewer treatments.
According to IBN Executive Director Professor Jackie Y. Ying, “Since 2003, IBN has adopted a multi-pronged approach toward cancer research. Our multidisciplinary research teams are working with various industrial, clinical and academic partners to develop new materials and tools to improve cancer diagnosis and treatment. This latest breakthrough with our long-term partner, IBM Research promises more efficient administration of anti-cancer drugs and more effective treatment of breast cancer, which we hope would benefit breast cancer patients worldwide.”
Official Opening of the ARKRAY Singapore Laboratory at the Nanos
Left to right: Mr Shigeki Yamada (CEO, ARKRAY Marketing), Mr Lim Chuan Poh (Chairman, A*STAR), Mr Takeshi Matsuda (President, ARKRAY), Prof Jackie Y. Ying (Executive Director, IBN), Mrs Sunako Doi (Chairperson, ARKRAY) and Dr Atsushi Murakami (GM of R&D, ARKRAY) at the official opening of the ARKRAY Singapore Laboratory at the Nanos.
August 29, 2013 – IBN congratulates ARKRAY on the official opening of its ARKRAY Singapore Laboratory at the Nanos, Biopolis on 29 August 2013. This is the first ARKRAY overseas research center outside Japan. It will house 21 employees and will partner with IBN to develop novel diagnostic kits for infectious diseases.
Read more about ARKRAY’s partnership with IBN here.
Left to right: Mr Takeshi Matsuda (President, ARKRAY), Dr Atsushi Murakami (GM of R&D, ARKRAY), Mrs Sunako Doi (Chairperson, ARKRAY), Mr Shigeki Yamada (CEO, ARKRAY Marketing), Mr Lim Chuan Poh (Chairman, A*STAR), Mr Suresh Sachi (Deputy Managing Director, A*STAR), Professor Jackie Y. Ying (Executive Director, IBN), Dr Benjamin Seet (Executive Director, BMRC) and A/Prof Tan Sze Wee (Deputy Executive Director, BMRC) in the Nanos.
Left to right: Dr Jianhao Bai (Research Scientist, IBN), Dr Yong Yeow Lee (Research Scientist, IBN), Dr Yuka Miyake (Senior Scientist, ARKRAY Singapore Laboratory) and Dr Masashi Tsukada (Senior Scientist, ARKRAY Singapore Laboratory).
IBN in the News
Improving Drug Delivery for Breast Cancer Treatment
A*STAR Research, 04 Dec 2013
Nanotechnology Experts to Gather in Singapore for 3rd Nano Today conference
Nanotechnology Now , 03 Dec 2013
New Hydrogel Helps Reduce Breast Cancer Tumor Size in Fewer Treatments than Traditional Therapies
Financial News, 05 Nov 2013
8 Dec - 11 Dec
3rd Nano Today Conference
Co-Delivery of Thioridazine and Doxorubicin Using Polymeric Micelles for Targeting Both Cancer Cells and Cancer Stem Cells
Biomaterials, 35 (2014) 1096-1108.
(IF: 7.604) article
Injectable Hydrogels from Triblock Copolymers of Vitamin E-Functionalized Polycarbonate and Poly(ethylene glycol) for Subcutaneous Delivery of Antibodies for Cancer Therapy
Advanced Functional Materials, (2013)
(IF: 9.765) article
Fine Control Over the Size of Surfactant−Polyelectrolyte Nanoparticles by Hydrodynamic Flow Focusing
Analytical Chemistry, 85 (2013) 5850-5856.
(IF: 5.695) article
Facilities and Safety Positions